Our people

Latest

Neuroblastoma Fact Sheet

Download our Neuroblastoma Fact Sheet for a comprehensive overview of the children's cancer neuroblastoma.
Digital Entertainment Subscriptions

Save on family favourites these school holidays with your Entertainment Membership AND support Neuroblastoma Australia.
September Childhood Cancer Awareness Month

September is Childhood Cancer Awareness Month! Share our hope for a cure for ALL types of neuroblastoma during September. Help us raise awareness this month - #GoGold!
Because of Piper

In memory of our princess Piper who passed away before she was 2 years old, leaving behind a heart broker Mum, Dad and two big brothers.

Dr Steve DuBois

Dr. DuBois is director of experimental therapeutics at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. He is a pediatric oncologist with an active clinical and translational research program focused on patients with advanced neuroblastoma and Ewing sarcoma. He conducts phase 1 and 2 clinical trials of novel targeted agents. His clinical practice focuses on providing outstanding team-based care for children and young adults with solid cancers.
Associate Professor Juliet Gray

Dr. Juliet Gray is an Associate Professor in Paediatric Oncology at the Cancer Immunology Centre, University of Southampton. She leads a translational research group focused on novel antibody immunotherapies for neuroblastoma, including preclinical evaluation of novel combinational therapies as well as early phase clinical trials.
Sarah White

Sarah is a paediatric Occupational Therapist and is passionate about working with children and families. Sarah brings 20 years experience working in private, not for profit and government health roles specifically in childhood disability and mental health. Since her daughter Isabella was diagnosed with Stage 3 Neuroblastoma in 2011, Sarah has been actively involved in creating awareness and fundraising for Neuroblastoma research.
Isabella Mannix

Isabella has a background in Marketing and Sales, with twenty years’ experience working in a variety of senior roles within the Financial Services sector and more recently the Health sector. After her daughter Georgia was diagnosed with Stage 1 Neuroblastoma in 2012, Isabella and her family have supported various childrens’ cancer charities – including the Childrens’ Cancer Institute, the Kids Cancer Project, Redkite and Neuroblastoma Australia.
Sarah Jones

Passionate about working with children, Sarah is a mum of three with a teaching qualification, who is currently pursuing postgraduate studies in Special Education. Sarah has experience in the not-for-profit sector, having worked for many years at The Starlight Children’s Foundation helping to develop in-hospital entertainment programs for seriously ill children. Sarah has been involved with fundraising for research into Neuroblastoma for over 5 years.
Our Scientific Advisory Board
Dr Louise Causer

Louise is a medical epidemiologist and lecturer currently based at The Kirby Institute, UNSW Australia and has worked internationally both in clinical and research settings across a number of fields. Having trained and working in a highly academic setting for the past decade, Louise has direct experience and key insight into the research setting in Australia and internationally.
Jane Price

Jane Price holds a Bachelor of Arts and a Bachelor of Laws. She is a small business owner, running her own immigration consultancy business, which she has grown in a few short years into a thriving practice with a couple of employees. Jane is lucky enough to have a “pigeon-pair” of children (aged 11 & 14) and was also privileged to know Sienna Hoffman.
Rochelle Yates

Rochelle is a mother of two, and Chairman of a global logistics company where she specialises in marketing. Rochelle's career includes vast experience in events and promotions and she has brought this skill to help coordinate numerous fundraising events and activities for Neuroblastoma Australia.
Professor Andy Pearson

Prof Andy Pearson is formerly a Cancer Research UK Professor of Paediatric Oncology, at the Institute of Cancer Research and the Royal Marsden Hospital NHS Trust. During a long and distinguished career, he helped establish and led many key groups in the paediatric oncology landscape both nationally and internationally.

Run2Cure Domain 2020: postponed to 2021

We need to ensure we play our part within the community and put safety first so Run2Cure Domain 2020 will now take place on 30th May 2021. In the meantime, please join us for Run2Cure Local! In our first virtual event do your own run or walk (1k, 3k, 5k or 10k) over the weekend of the 5th and 6th of September and support a cure to the children’s cancer neuroblastoma.
Accessibility

Neuroblastoma Australia is committed to providing a website that is accessible to the widest possible audience, regardless of technology or ability. Our website endeavours to conform to level Double-A of the World Wide Web Consortium W3C Web Content Accessibility Guidelines 2.0.
Kahlilla's Story #14km

Little Lilla's light continues to shine. Always and forever.
Detection, diagnosis & staging

Most symptoms of neuroblastoma are caused by the growth of the cancer into nearby tissues or organs, or its spread to distant parts of the body such as bones or bone marrow.
What is neuroblastoma?

Neuroblastomas are cancers that start in early nerve cells (called neuroblasts) of the sympathetic nervous system. This means that tumours can be found anywhere along this system; most commonly (about 50%) start in the adrenal glands (above the kidney), or near the spine, chest, neck or pelvis.
Childhood Cancer Awareness Month

September is Childhood Cancer Awareness Month. Share our hope for a cure for ALL types of neuroblastoma during September. More children under five die from neuroblastoma than from any other childhood cancer.
Golf2Cure 2021

We are delighted to announce that our Golf2Cure Neuroblastoma 2020 event will be held on the NEW date of Friday 12th Feb 2021 at St Michael’s, Little Bay.
Summer's Story #34

Summer battled for 15 months and gained her wings 22 December 2018. Very loved and missed by her family especially her three brothers
Urgent Appeal - Venetoclax

Venetoclax is a promising drug currently in trial for a number of cancers, including neuroblastoma BUT in combination with another agent we think it'll perform even better. Dr Jamie Fletcher from the Children's Cancer Institute needs funding to identify these combinations. Can you help us make this happen?
Two research grants awarded

Today we announced funding grants to two ground breaking research projects which we hope will take us a step close to finding a cure for the rare and deadly children’s cancer neuroblastoma.